Medi Futures develops ultrasonic technology for medical devices, enhancing precision in surgical procedures and improving patient outcomes. The company also explores the use of adipose-derived stem cells in regenerative medicine, offering new therapeutic options for patients with various health conditions.
Funding
Funding not disclosed
Founders
Product
Problem
Traditional surgical methods can cause significant tissue damage and complications, while existing cell separation techniques often rely on harsh chemicals that can harm the cells themselves. This limits the effectiveness and safety of both surgical procedures and regenerative medicine applications.
Solution
Medi Futures develops and commercializes ultrasonic technology-based healthcare solutions. Their core offerings include ultrasonic surgical devices designed to minimize tissue damage during procedures, and a novel enzyme-free ultrasonic stem cell separation technology. This technology allows for the isolation of viable stem cells without the use of harsh chemicals, preserving their integrity for regenerative medicine applications. Medi Futures' products aim to improve patient outcomes by enhancing precision and safety in surgical interventions and enabling more effective cell-based therapies.
Target Audience
The primary target audience includes surgeons, medical professionals in regenerative medicine, and consumers seeking advanced healthcare and cosmetic solutions.
Features
- Ultrasonic surgical devices that minimize damage to surrounding tissues and blood vessels
- Enzyme-free ultrasonic stem cell separation technology for isolating high-quality stem cells
- Davinci Cog: Ultrasonic-processed barbed sutures with enhanced precision and durability
- Ultrasonic PDO Lifting Threads: Polydioxanone threads made via ultrasonic vibration for cosmetic surgery with increased tensile force and anchoring strength
- Applications in bio, medical device, and consumer healthcare sectors
- RBFY (ReBorn For You) line of cosmetics